{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:54:50Z","timestamp":1783338890827,"version":"3.54.6"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s12020-019-01957-2","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T08:03:32Z","timestamp":1562313812000},"page":"623-629","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Differential expression of RET isoforms in normal thyroid tissues, papillary and medullary thyroid carcinomas"],"prefix":"10.1007","volume":"65","author":[{"given":"Teresa","family":"Ramone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5957-8902","authenticated-orcid":false,"given":"Cristina","family":"Romei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Ciampi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Tacito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Piaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liborio","family":"Torregrossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Ugolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Elisei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,5]]},"reference":[{"key":"1957_CR1","doi-asserted-by":"crossref","unstructured":"P. Durbec, C.V. Marcos-Gutierrez, C. Kilkenny, M. Grigoriou, K. Wartiowaara, P. Suvanto, D. Smith, B. Ponder, F. Costantini, M. Saarma, GDNF signalling through the Ret receptor tyrosine kinase. Nature 381, 789 (1996)","DOI":"10.1038\/381789a0"},{"key":"1957_CR2","doi-asserted-by":"crossref","unstructured":"R.H. Baloh, H. Enomoto, E.M.J. Johnson, J. Milbrandt, The GDNF family ligands and receptors - implications for neural development. Curr. Opin. Neurobiol. 10, 103 (2000)","DOI":"10.1016\/S0959-4388(99)00048-3"},{"key":"1957_CR3","doi-asserted-by":"crossref","unstructured":"E. Arighi, M.G. Borrello, H. Sariola, RET tyrosine kinase signaling in development and cancer. Cytokine Growth Factor Rev. 16, 441 (2005)","DOI":"10.1016\/j.cytogfr.2005.05.010"},{"key":"1957_CR4","doi-asserted-by":"crossref","unstructured":"K. Takaya, T. Yoshimasa, H. Arai, N. Tamura, Y. Miyamoto, H. Itoh, K. Nakao, Expression of the RET proto-oncogene in normal human tissues, pheochromocytomas, and other tumors of neural crest origin. J. Mol. Med (Berl.) 74, 617 (1996)","DOI":"10.1007\/s001090050065"},{"key":"1957_CR5","doi-asserted-by":"crossref","unstructured":"P. Kjellman, D.L. Learoyd, M. Messina, G. Weber, A. Hoog, G. Wallin, C. Larsson, B.G. Robinson, J. Zedenius, Expression of the RET proto-oncogene in papillary thyroid carcinoma and its correlation with clinical outcome. Br. J. Surg. 88, 557 (2001)","DOI":"10.1046\/j.1365-2168.2001.01734.x"},{"key":"1957_CR6","doi-asserted-by":"crossref","unstructured":"M. Inaba, S. Umemura, H. Satoh, Y. Abe, K. Kurokawa, H. Sakai, R.Y. Osamura, Expression of RET in follicular cell-derived tumors of the thyroid gland: prevalence and implication of morphological type. Pathol. Int. 53, 146 (2003)","DOI":"10.1046\/j.1440-1827.2003.01447.x"},{"key":"1957_CR7","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/sj.onc.1204161","volume":"20","author":"O Fluge","year":"2001","unstructured":"O. Fluge, D.R. Haugen, L.A. Akslen, A. Marstad, M. Santoro, A. Fusco, J.E. Varhaug, J.R. Lillehaug, Oncogene 20, 885 (2001)","journal-title":"Oncogene"},{"key":"1957_CR8","doi-asserted-by":"crossref","unstructured":"S.M. Ivanchuk, S.M. Myers, L.M. Mulligan, Expression and alternative splicing of c-ret RNA in papillary thyroid carcinomas. Oncogene 16, 991 (1998)","DOI":"10.1038\/sj.onc.1201622"},{"key":"1957_CR9","unstructured":"T. Tahira, Y. Ishizaka, F. Itoh, T. Sugimura, M. Nagao, Tahira, Y. Ishizaka, F. Itoh, T. Sugimura, M. Nagao, Expression of the ret proto-oncogene in human neuroblastoma cell lines and its increase during neuronal differentiation induced by retinoic acid. Oncogene 5, 97 (1990)"},{"key":"1957_CR10","unstructured":"S.M. Myers, C. Eng, B.A. Ponder, L.M. Mulligan, Characterization of RET proto-oncogene 3' splicing variants and polyadenylation sites: a novel C-terminus for RET. Oncogene 11, 2039 (1995)"},{"key":"1957_CR11","doi-asserted-by":"crossref","unstructured":"H. Le Hir, N. Charlet-Berguerand, A. Gimenez-Roqueplo, M. Mannelli, P. Plouin, V. de Franciscis, C. Thermes, Relative expression of the RET9 and RET51 isoforms in human pheochromocytomas. Oncology 58, 311 (2000)","DOI":"10.1159\/000012118"},{"key":"1957_CR12","doi-asserted-by":"crossref","unstructured":"D.S. Richardson, D.M. Rodrigues, B.D. Hyndman, M.J.F. Crupi, A.C. Nicolescu, L.M. Mulligan, Alternative splicing results in RET isoforms with distinct trafficking properties. Mol. Biol. Cell. 23, 3838 (2012)","DOI":"10.1091\/mbc.e12-02-0114"},{"key":"1957_CR13","doi-asserted-by":"crossref","unstructured":"E.Y. Lian, S.M. Maritan, J.G. Cockburn, K. Kasaian, M.J.F. Crupi, D. Hurlbut, S.J.M. Jones, S.M. Wiseman, L.M. Mulligan, Differential roles of RET isoforms in medullary and papillary thyroid carcinomas. Endocr. Relat. Cancer 24, 53 (2017)","DOI":"10.1530\/ERC-16-0393"},{"key":"1957_CR14","doi-asserted-by":"crossref","unstructured":"C. Romei, R. Ciampi, R. Elisei, A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma. Nat. Rev. Endocrinol. 12, 192 (2016)","DOI":"10.1038\/nrendo.2016.11"},{"key":"1957_CR15","unstructured":"G. Bunone, M. Uggeri, P. Mondellini, M.A. Pierotti, I. Bongarzone, RET receptor expression in thyroid follicular epithelial cell-derived tumors. Cancer Res. 60, 2845 (2000)"},{"key":"1957_CR16","doi-asserted-by":"crossref","unstructured":"M.T. Carter, J.L. Yome, M.N. Marcil, C.A. Martin, J.B. Vanhorne, L.M. Mulligan, Conservation of RET proto-oncogene splicing variants and implications for RET isoform function. Cytogenet. Cell Genet. 95, 169 (2001)","DOI":"10.1159\/000059341"},{"key":"1957_CR17","doi-asserted-by":"crossref","unstructured":"M. Rossel, A. Pasini, S. Chappuis, O. Geneste, L. Fournier, I. Schuffenecker, M. Takahashi, L.A. van Grunsven, J.L. Urdiales, B.B. Rudkin, G.M. Lenoir, M. Billaud, Distinct biological properties of two RET isoforms activated by MEN 2A and MEN 2B mutations. Oncogene 14, 265 (1997)","DOI":"10.1038\/sj.onc.1200831"},{"key":"1957_CR18","doi-asserted-by":"crossref","unstructured":"T. Iwashita, M. Kato, H. Murakami, N. Asai, Y. Ishiguro, S. Ito, Y. Iwata, K. Kawai, M. Asai, K. Kurokawa, H. Kajita, M. Takahashi, Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma. Oncogene 18, 3919 (1999)","DOI":"10.1038\/sj.onc.1202742"},{"key":"1957_CR19","doi-asserted-by":"crossref","unstructured":"J. Turchini, V.K.Y. Cheung, A.S. Tischler, R.R. De Krijger, A.J. Gill, Pathology and genetics of phaeochromocytoma and paraganglioma. Histopathology 72, 97 (2018)","DOI":"10.1111\/his.13402"},{"key":"1957_CR20","doi-asserted-by":"crossref","unstructured":"C. Guerin, P. Romanet, D. Taieb, T. Brue, A. Lacroix, F. Sebag, A. Barlier, F. Castinetti, Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms. Endocr. Relat. Cancer 25, T15 (2018)","DOI":"10.1530\/ERC-17-0266"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-019-01957-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-019-01957-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-019-01957-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T23:31:31Z","timestamp":1593819091000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-019-01957-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,5]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1957"],"URL":"https:\/\/doi.org\/10.1007\/s12020-019-01957-2","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,5]]},"assertion":[{"value":"25 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest that could affect the impartiality of the reported research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}